Patient and Provider Perspectives on Genetic Risk Profiling
NCT07741929 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2026-08-03
Summary
A qualitative interview study exploring the patient and provider perspectives on the clinical utility of genetic risk profiling in routine clinical practice. The findings from the study may contribute towards future research and informing clinical practice.
Conditions
Interventions
- OTHER
-
Qualitative interview
Interview of participants to gain perspectives and experiences
Sponsors & Collaborators
-
Institute of Cancer Research, United Kingdom
collaborator OTHER -
Royal Marsden NHS Foundation Trust
lead OTHER
Principal Investigators
-
Elizabeth Bancroft, RN PhD · The Royal Marsden NHS Foundation Trust / The Institute of Cancer Research
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-05-01
- Primary Completion
- 2027-08-31
- Completion
- 2027-08-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Studying Genes, Environment, and Prostate Cancer Risk in Patients With or Without Prostate Cancer
NCT01013129 ·Status: COMPLETED
-
Prophylactic Prostatectomy for Prostate Cancer (PPPC)
NCT06470685 ·Status: ENROLLING_BY_INVITATION
-
Micro-RNA Expression Profiles in High Risk Prostate Cancer
NCT01220427 ·Status: TERMINATED
-
Understanding of Genetics by Men at Risk for Prostate Cancer
NCT04550845 ·Status: RECRUITING ·Phase: NA
-
Facilitating Participation in a Prostate Cancer Risk Assessment Program
NCT02126319 ·Status: COMPLETED ·Phase: NA
-
Familial Prostate Cancer
NCT00001377 ·Status: COMPLETED
-
The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer
NCT00261456 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Validity and Utility of Genomic-targeted Chemoprevention of PCa: Aim 4a
NCT02381015 ·Status: COMPLETED ·Phase: NA
-
Genetics of Prostate Cancer in Young Patients
NCT06714227 ·Status: COMPLETED
-
Prostate Cancer Prevention Clinic for Men With Risk of Familial Prostate Cancer
NCT05681416 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations
NCT02705846 ·Status: RECRUITING
-
Identification of Prostate Cancer Genes
NCT00342784 ·Status: COMPLETED
-
The ProCaRis Study: Prostate Cancer Risk Assessment in General Practice
NCT01739062 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy
NCT05295407 ·Status: RECRUITING
-
Exploiting Risk-Based Risk Stratification in Early Prostate Cancer to Discriminate Progressors From Non-Progressors
NCT04340245 ·Status: ACTIVE_NOT_RECRUITING
-
A Tailored Polygenic Risk Score for Predicting Progression in Prostate Cancer Under Active Surveillance
NCT07491406 ·Status: COMPLETED
-
Study of Treatment Choice in Patients With Localized Prostate Cancer
NCT01177865 ·Status: UNKNOWN ·Phase: NA
-
Streamlined Genetic Testing in Prostate Cancer
NCT04359758 ·Status: COMPLETED ·Phase: NA
-
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
NCT04472338 ·Status: RECRUITING
-
Development of a Novel Signature Integrating Clinical, Imaging And Epigenetic Information to Tailor Pelvic Nodal Treatment in Prostate Cancer
NCT06807398 ·Status: COMPLETED
-
Prostate Cancer Screening in Men With Germline BRCA2 Mutations
NCT02154672 ·Status: COMPLETED
-
DRG Mutations in Prostate Cancer: a Guiding Light for Enhanced Screening and Personalised Therapy
NCT07265414 ·Status: ACTIVE_NOT_RECRUITING
-
The Active Surveillance Study
NCT05810467 ·Status: RECRUITING
-
Prognostic Factors in Prostate Cancer for Patients Treated by Watchful Waiting
NCT03912883 ·Status: ACTIVE_NOT_RECRUITING
-
Non-Invasive Biomarkers in Prostate Cancer Disease Management
NCT06144619 ·Status: SUSPENDED